| Primary |
| Hiv Infection |
44.1% |
| Drug Use For Unknown Indication |
23.8% |
| Systemic Antiviral Treatment |
11.3% |
| Infection |
5.2% |
| Product Used For Unknown Indication |
4.2% |
| Antiviral Treatment |
2.7% |
| Anti-infective Therapy |
1.0% |
| Cd4 Lymphocytes Decreased |
1.0% |
| Hypertension |
1.0% |
| Prophylaxis Against Hiv Infection |
1.0% |
| Acute Hiv Infection |
0.6% |
| Hepatitis C |
0.6% |
| Trigeminal Neuralgia |
0.6% |
| Anaemia Prophylaxis |
0.5% |
| Depression |
0.5% |
| Hiv Test Positive |
0.5% |
| Hypokalaemia |
0.5% |
| Insomnia |
0.3% |
| Mycobacterium Avium Complex Infection |
0.3% |
| Premature Labour |
0.3% |
|
| Normal Newborn |
17.6% |
| Trisomy 21 |
8.8% |
| Drug Exposure During Pregnancy |
5.5% |
| Renal Failure Chronic |
5.5% |
| Vomiting |
5.5% |
| Diaphragmatic Hernia |
4.4% |
| Hydronephrosis |
4.4% |
| Polydactyly |
4.4% |
| Renal Failure |
4.4% |
| Renal Failure Acute |
4.4% |
| Unevaluable Event |
4.4% |
| Weight Increased |
4.4% |
| Abortion Spontaneous |
3.3% |
| Atrial Fibrillation |
3.3% |
| Coronary Artery Disease |
3.3% |
| Hypersomnia |
3.3% |
| Maternal Exposure Timing Unspecified |
3.3% |
| Nuclear Magnetic Resonance Imaging Brain Abnormal |
3.3% |
| Oesophageal Atresia |
3.3% |
| Pregnancy |
3.3% |
|
| Secondary |
| Hiv Infection |
59.5% |
| Drug Use For Unknown Indication |
12.2% |
| Drug Exposure During Pregnancy |
5.8% |
| Antiretroviral Therapy |
2.9% |
| Acquired Immunodeficiency Syndrome |
2.9% |
| Agitation |
2.1% |
| Opportunistic Infection Prophylaxis |
1.8% |
| Infection |
1.7% |
| Hiv Test Positive |
1.3% |
| Atypical Mycobacterial Infection |
1.1% |
| Product Used For Unknown Indication |
1.1% |
| Cd4 Lymphocytes Decreased |
1.0% |
| Prophylaxis |
1.0% |
| Trigeminal Neuralgia |
1.0% |
| Antiviral Prophylaxis |
0.9% |
| Antiviral Treatment |
0.9% |
| Toxoplasmosis |
0.8% |
| Antifungal Prophylaxis |
0.7% |
| Maternal Exposure Timing Unspecified |
0.7% |
| Maternal Exposure During Pregnancy |
0.6% |
|
| Vitamin B12 Deficiency |
9.2% |
| Vomiting |
9.2% |
| Pregnancy |
8.0% |
| Ventricular Extrasystoles |
8.0% |
| Normal Newborn |
6.7% |
| Pulmonary Hypertension |
6.7% |
| Laboratory Test Abnormal |
6.1% |
| Drug Exposure During Pregnancy |
4.9% |
| Trisomy 21 |
4.9% |
| Renal Colic |
4.3% |
| Palpitations |
3.7% |
| Pseudomembranous Colitis |
3.7% |
| Renal Failure Chronic |
3.7% |
| Spine Malformation |
3.7% |
| Renal Failure Acute |
3.1% |
| Thrombocytopenia |
3.1% |
| Weight Decreased |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| Myocardial Infarction |
2.5% |
| Neutropenia |
2.5% |
|
| Concomitant |
| Hiv Infection |
64.1% |
| Product Used For Unknown Indication |
5.1% |
| Acquired Immunodeficiency Syndrome |
4.6% |
| Drug Use For Unknown Indication |
4.0% |
| Hepatitis C |
2.6% |
| Antiretroviral Therapy |
2.2% |
| Hiv Test Positive |
2.0% |
| Antibiotic Therapy |
1.8% |
| Mycobacterium Avium Complex Infection |
1.5% |
| Oesophageal Candidiasis |
1.3% |
| Antifungal Prophylaxis |
1.2% |
| Factor Viii Deficiency |
1.2% |
| Haemorrhoids |
1.2% |
| Human Immunodeficiency Virus Transmission |
1.2% |
| Cytomegalovirus Chorioretinitis |
1.1% |
| Lymphoma |
1.1% |
| Pyrexia |
1.1% |
| Mycobacteria Test |
1.0% |
| Trigeminal Neuralgia |
0.9% |
| Gastrooesophageal Reflux Disease |
0.8% |
|
| Vomiting |
13.6% |
| Renal Failure Acute |
7.8% |
| Pyrexia |
6.8% |
| Squamous Cell Carcinoma |
6.8% |
| Syncope |
5.8% |
| Thrombocytopenia |
5.8% |
| Anaemia |
4.9% |
| Vitamin D Deficiency |
4.9% |
| Weight Decreased |
4.9% |
| Cardiomyopathy |
3.9% |
| Drug Exposure During Pregnancy |
3.9% |
| Interstitial Lung Disease |
3.9% |
| Lymphoma |
3.9% |
| Neutropenia |
3.9% |
| Osteonecrosis |
3.9% |
| Pancytopenia |
3.9% |
| Atrial Fibrillation |
2.9% |
| Enlarged Clitoris |
2.9% |
| Haemoglobin Decreased |
2.9% |
| Muscular Weakness |
2.9% |
|
| Interacting |
|
|
